An estimates-topping quarterly earnings report from Evolution Metals & Technologies (EMAT +2.60%) published after market close on Monday was tempered by a scathing critique of the company. All in all, though, investors chose to focus on the positive, and collectively they sent Evolution’s stock up by nearly 3% on the day.

Topping estimates

Evolution, a relatively early-stage company that concentrates on the production of rare-earth magnets, earned revenue of $2.2 million in its third quarter. This was 36% higher than its take in the previous quarter; it earned no revenue in the third quarter of 2025. Its non-GAAP (adjusted) net loss deepened to $13.4 million, or $0.02 per share, from the year-ago quarter’s $4 million shortfall.

Person in a wheelchair at a workstation with two monitors

Image source: Getty Images.

Both headline figures were high enough to exceed the consensus analyst estimates. On average, prognosticators following Evolution stock were estimating revenue of $1.95 million and an adjusted net loss per share of $0.03.

Evolution also had encouraging news to report, but this concerned its current (fourth) quarter. In October, it received the entire order of 13 sintered rare-earth magnet production machines from a Korean unit of the vacuum equipment manufacturer Ulvac. Once installed at the company’s expansion facility in that country, it will be able to significantly scale up its magnet production capacity.

EMAT Evolution Metals & Technologies

$0.71+$0.02 (+2.60%)

NASDAQ · As of 4:00 PM ET 11/17/26

Serious allegations

One entity that surely wasn’t as impressed with Evolution’s third quarter is short-seller Capybara Research. On Monday, Capybara published a blisteringly critical report on the company. The headline of the document reflected Capybara’s key criticisms, as it read “Evolution Metals: A cesspool of fraud. A $2 million payoff, convicted felons, insider trading, market manipulation and no material operations.”

On Tuesday, Evolution fired off a detailed response to the report, categorically refuting all the allegations. It added that it is considering engaging legal counsel to pursue claims against Capybara.

While short-sellers have a material interest in publishing negative material on a stock, allegations as serious as this should be examined. Any investor should be very careful with Evolution and dig deeply into the report and the company’s response before considering whether to buy the stock.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 802%* — a market-crushing outperformance compared to 205% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks ›

*Stock Advisor returns as of November 17, 2026.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *